Cargando…
Discovery of Small-Molecule Allosteric Inhibitors of PfATC as Antimalarials
[Image: see text] The discovery and development of new drugs against malaria remain urgent. Aspartate transcarbamoylase (ATC) has been suggested to be a promising target for antimalarial drug development. Here, we describe a series of small-molecule inhibitors of P. falciparum ATC with low nanomolar...
Autores principales: | Wang, Chao, Zhang, Bidong, Krüger, Arne, Du, Xiaochen, Visser, Lidia, Dömling, Alexander S S, Wrenger, Carsten, Groves, Matthew R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585585/ https://www.ncbi.nlm.nih.gov/pubmed/36195578 http://dx.doi.org/10.1021/jacs.2c08128 |
Ejemplares similares
-
Novel Highlight in Malarial Drug Discovery: Aspartate Transcarbamoylase
por: Wang, Chao, et al.
Publicado: (2022) -
Orthosteric–allosteric dual inhibitors of PfHT1 as selective antimalarial agents
por: Huang, Jian, et al.
Publicado: (2021) -
Molecular Modeling Applied to Nucleic Acid-Based Molecule Development
por: Krüger, Arne, et al.
Publicado: (2018) -
ATC -> ICD – evaluating the reliability of prognoses for ICD-10 diagnoses derived from the ATC-Code of prescriptions
por: Weisser, Andrea, et al.
Publicado: (2008) -
Dynamics of ACTH-Mediated Regulation of Gene Transcription in ATC1 and ATC7 Adrenal Zona Fasciculata Cell Lines
por: Hazell, Georgina, et al.
Publicado: (2019)